Your membership is expired. Please renew your membership to login. | Renew memberhip
If using IE11, please consider using an alternative browser.
Not a Member? In order to develop the most comprehensive beneficial standards for the healthcare industry we gather input, expertise, advocacy & leadership from our NCPDP members. Become a Member
We are more than a just standards development organization – we are a problem-solving forum for the healthcare industry. Over the years, we have made numerous contributions to improving efficiencies and patient safety not only through our standards but also through industry guidance. Our industry guidance is traditionally published in the form of a white paper.
Industry guidance spans a variety of topics including: the use of the Quantity Prescribed to address Schedule II controlled substances; Medicaid Drug Rebate Program; Billing Guidance for Pharmacists' Professional and Patient Care Services; and Dates Associated with Pharmaceutical Products.
Some examples of our industry guidance include the following:
Simplifies medication administration instructions for patients and car egivers, increase understanding of and adherence to medication instructions, and improve patient safety and health outcomes.
Addresses recommendations to address accidental overdose of acetaminophen, a public health issue. Soon after publishing its recommendations, pharmacy retailers – including CVS, Walgreens, Rite Aid, Walmart and Target – estimated to collectively represent more than half of the prescriptions dispensed in 2011, had either implemented or committed to a phased implementation of NCPDP’s recommendations.
The recommendations take a holistic view of systems, processes and people to identify opportunities for proactive intervention. The white paper includes best practices and guidance for reducing the risk of inadvertent acetaminophen overdose during clinical handoffs such as between units or departments and care transitions such as from the inpatient to ambulatory care setting.
Another important patient safety issue centers on the dosing of oral liquid medications which puts pediatric patients at particular risk, as healthcare professionals often rely on liquid medications for treating young children. NCPDP’s guidance document calls for standardization of dosing of oral liquid medication and labeling using mL, and the use of appropriate dosing devices to prevent harm from measurement errors – overdosing and underdosing.
NCPDP’s Elite Partners provide the highest level of support for the valuable work of NCPDP in advancing patient safety and interoperability. The following Elite Partners have demonstrated intense commitment to support NCPDP’s work, vision and core values.